A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

NCT00651807 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

DRUG: etonogestrel
DRUG: Placebo

Sponsor

Organon and Co